Benzanilide-Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4027546)

Published in ACS Med Chem Lett on March 04, 2013

Authors

Cristian Ochoa-Puentes1, Stefanie Bauer2, Matthias Kühnle2, Günther Bernhardt2, Armin Buschauer2, Burkhard König3

Author Affiliations

1: Institute of Organic Chemistry, University of Regensburg , D-93040 Regensburg, Germany ; Departamento de Química, Universidad Nacional de Colombia , Bogotá D.C., Colombia.
2: Institute of Pharmacy, University of Regensburg , D-93040 Regensburg, Germany.
3: Institute of Organic Chemistry, University of Regensburg , D-93040 Regensburg, Germany.

Articles cited by this

Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer (2002) 15.72

Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol Cancer Ther (2002) 2.60

Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res (2000) 2.32

Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo. J Clin Invest (2002) 1.90

Pheophorbide a is a specific probe for ABCG2 function and inhibition. Cancer Res (2004) 1.82

Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs. Trends Pharmacol Sci (2005) 1.59

Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR. Cancer Lett (1999) 1.52

The "specific" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2). ACS Chem Neurosci (2010) 1.46

Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar. J Med Chem (2009) 1.25

Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice. J Cancer Res Clin Oncol (2007) 1.10

Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2. Curr Med Chem Anticancer Agents (2004) 1.02

Antiproliferative agents that interfere with the cell cycle at the G1-->S transition: further development and characterization of a small library of stilbene-derived compounds. ChemMedChem (2008) 0.84

Solid phase synthesis of tariquidar-related modulators of ABC transporters preferring breast cancer resistance protein (ABCG2). Bioorg Med Chem Lett (2011) 0.80